Psoriasis trials in United Kingdom
13 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Sheffield, Stoke-on-Trent
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - Phase 3Taking peopleLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Where
- Bristol, High Wycombe, Kirkcaldy, London, Salford, Southampton
- Age
- 40 years and over
- People
- 3,040 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00 - No phaseTaking peopleTreatment Effectiveness in People With axSpA or PsA Starting Treatment With Bimekizumab, Risankizumab, Guselkumab, Upadacitinib, or a TNF Inhibitor
- Where
- Bath
- Age
- 18 years and over
- People
- 700
- Run by
- Adelphi Real World
See details and how to joinNCT07166315 - Phase 3Taking peopleA Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Connor Downs, London
- Age
- 4 years to 18 years
- People
- 153 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00 - No phaseNot yet taking people in United KingdomEvidencing Vibroacoustic Sensing for Inflammatory Skin Disease Monitoring
- Where
- Edinburgh
- Age
- 18 years to 75 years
- People
- 20
- Run by
- University of Edinburgh
See details and how to joinNCT07846813 - Phase 3Taking peopleA Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Where
- Bristol, Liverpool, Sheffield
- Age
- 5 years to 17 years
- People
- 40 worldwide
- Run by
- AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00 - No phaseTaking peopleSEquential Treatment of PSoriasis With Biologics
- Where
- Bath
- Age
- 18 years and over
- People
- 366
- Run by
- Royal United Hospitals Bath NHS Foundation Trust
See details and how to joinNCT07187817 - No phaseNot yet taking people in United KingdomA Study of Clinical and Immune Responses to Sequential Biologic Therapies in Psoriatic Arthritis
- Where
- Bath
- Age
- 18 years and over
- People
- 400
- Run by
- Royal United Hospitals Bath NHS Foundation Trust
See details and how to joinNCT07417995 - No phaseTaking peopleCombination of Biologic and Anti-obesity Therapies in Psoriatic Arthritis
- Where
- Birmingham, Coventry, Glasgow, Newcastle upon Tyne
- Age
- 18 years to 75 years
- People
- 45
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07443956 - No phaseNot yet taking people in United KingdomRewiring the Brain-Immune Axis for Chronic Pain Using Transcranial Magnetic Stimulation in Psoriatic Arthritis
- Where
- Glasgow
- Age
- 18 years to 75 years
- People
- 40
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT07403890 - No phaseTaking peopleEvaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
- Where
- Glasgow
- Age
- 18 years to 74 years
- People
- 50
- Run by
- NHS Greater Glasgow and Clyde
See details and how to joinNCT06786936 - No phaseTaking peopleHIPPOCRATES Prospective Observational Study
- Where
- Oxford
- Age
- 18 years and over
- People
- 25,000
- Run by
- University of Oxford
See details and how to joinNCT05858528 - No phaseTaking peopleWalk and Talk: Connecting People With Psoriasis
- Where
- London
- Age
- 18 years and over
- People
- 170
- Run by
- Royal Free Hospital NHS Foundation Trust
See details and how to joinNCT06726213